Forum Discussion
CTS5 Online Test for determining if only five years of hormone therapy is okay instead of ten
Hi Perhaps this is old news, but I searched BCNA online network and couldn’t find a reference in the posts to CTS5. I have heard vaguely of this before, but this is the first specific reference...
I agree with @kmakm
On the research I read the endocrine therapy was only beneficial for local recurrence or locally advanced ...nodes and preventing contralactal breast cancer. It didn't make any difference in reduction of distant mestastes it seems.
On the research I read the endocrine therapy was only beneficial for local recurrence or locally advanced ...nodes and preventing contralactal breast cancer. It didn't make any difference in reduction of distant mestastes it seems.
Updated guideline recommendations
The updated guidelines are based on the results of six large trials looking at whether taking an aromatase inhibitor for more than 5 years offered additional benefits. The studies found that extended aromatase inhibitor treatment didn’t seem to improve overall survival, but it did significantly reduce the risk of breast cancer recurrence and the risk of breast cancer developing in the opposite breast.
Here's the full article. It's all doing my head in really.
https://www.breastcancer.org/research-news/asco-recommends-extended-hormonal-tx-for-some